Post Profile






Hormone identified that limits liver fibrosis

(Kobe University) Nonalcoholic steatohepatitis has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis. A Japanese research team has identified and clarified the mechanism for a hormone that limits the fibrosis associated with NASH and cirrhosis. This discovery has potential applications for the treatment of these conditions.
read more

share

Related Posts


Estrogen protects women with NASH from severe liver fibrosis

Academics / General Science : Science Codex

New research suggests that estrogen protects women with nonalcoholic steatohepatitis (NASH) from severe liver fibrosis. According to the study published online in Hepatology, a journal of the American Association for the Study of Li...

Technique May Identify Patients with Fast-Progressing Fibrosis in Nonalcoholic Fatty Liver Disease

Health : Newswise Medical News

Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and...

Technique may identify patients with fast-progressing fibrosis in nonalcoholic fatty liver disease

Health : EurekAlert: Health

(University of California - San Diego) Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver di...

Estrogen protects women with NASH from severe liver fibrosis

Academics / General Science : ScienceDaily: Science Society

New research suggests that estrogen protects women with nonalcoholic steatohepatitis from severe liver fibrosis. According to research, men are at higher risk of more severe fibrosis compared to women prior to menopause, but liver f...

Medical News Today: Nonalcoholic fatty liver disease: Hormone that limits fibrosis discovered

Health : Medical News Today

Scientists discover the hormone IGF-I limits the fibrosis associated with nonalcoholic steatohepatitis - a progression of nonalcoholic fatty liver disease.

Comments


Copyright © 2016 Regator, LLC